Try our Advanced Search for more refined results

April 06, 2022

QIAGEN Hamburg GmbH et al v. Bio-Rad Laboratories, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 07, 2022

    Bio-Rad Rival Wants Its COVID Test Tech Cleared Of IP Claims

    The German molecular diagnostics provider Qiagen hit Bio-Rad Laboratories Inc. with a lawsuit in Delaware federal court Wednesday, asking a judge to declare that its QIAcuity technology used to quickly test municipal sewer systems across the U.S. for COVID-19 outbreaks doesn't infringe six Bio-Rad diagnostics patents.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!